|
GB8613481D0
(en)
|
1986-06-04 |
1986-07-09 |
Diatech Ltd |
Translation of mrna
|
|
US6867195B1
(en)
|
1989-03-21 |
2005-03-15 |
Vical Incorporated |
Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
GB9103974D0
(en)
|
1991-02-26 |
1991-04-10 |
Norsk Hydro As |
Therapeutically useful peptides or peptide fragments
|
|
US5723332A
(en)
|
1993-11-26 |
1998-03-03 |
British Technology Group Limited |
Translational enhancer DNA
|
|
AU3559695A
(en)
|
1994-09-30 |
1996-04-26 |
Inex Pharmaceuticals Corp. |
Glycosylated protein-liposome conjugates and methods for their preparation
|
|
US5824497A
(en)
|
1995-02-10 |
1998-10-20 |
Mcmaster University |
High efficiency translation of mRNA molecules
|
|
US6503503B1
(en)
|
1997-05-13 |
2003-01-07 |
Duke University |
Allogeneic cellular vaccine
|
|
US6080725A
(en)
|
1997-05-20 |
2000-06-27 |
Galenica Pharmaceuticals, Inc. |
Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
|
|
GB2328689A
(en)
|
1997-08-27 |
1999-03-03 |
Norsk Hydro As |
Peptides based on the p21 ras proto-oncogene protein for the treatment of cancer
|
|
US20060009633A9
(en)
|
1997-11-13 |
2006-01-12 |
Genset, S.A. |
Complementary DNAs encoding proteins with signal peptides
|
|
NO309798B1
(no)
|
1999-04-30 |
2001-04-02 |
Targovax As |
Peptidblanding, samt farmasoytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
|
|
ATE291925T1
(de)
|
2001-06-05 |
2005-04-15 |
Curevac Gmbh |
Stabilisierte mrna mit erhöhtem g/c-gehalt und optimierter codon usage für die gentherapie
|
|
EP2428570B1
(en)
|
2001-09-28 |
2018-05-23 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Microrna molecules
|
|
WO2003048202A2
(en)
|
2001-12-03 |
2003-06-12 |
Asahi Kasei Pharma Corporation |
Nf-kappab activating genes
|
|
US20050222064A1
(en)
|
2002-02-20 |
2005-10-06 |
Sirna Therapeutics, Inc. |
Polycationic compositions for cellular delivery of polynucleotides
|
|
GB0221574D0
(en)
|
2002-09-17 |
2002-10-23 |
Isis Innovation |
Treatments
|
|
WO2004037284A1
(en)
|
2002-10-22 |
2004-05-06 |
Sanofi Pasteur Limited |
Anti-cancer vaccines and high-dose cytokines as adjuvants
|
|
AU2003298607B9
(en)
|
2002-10-29 |
2011-08-04 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US8343502B2
(en)
|
2002-12-16 |
2013-01-01 |
Globeimmune, Inc. |
Yeast-based vaccines as immunotherapy
|
|
JP4914990B2
(ja)
|
2002-12-16 |
2012-04-11 |
グローブイミューン,インコーポレイテッド |
動物を癌から守るための治療用組成物
|
|
WO2005013901A2
(en)
|
2003-07-31 |
2005-02-17 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding rnas
|
|
US7404969B2
(en)
|
2005-02-14 |
2008-07-29 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
|
PL2578685T3
(pl)
|
2005-08-23 |
2020-01-31 |
The Trustees Of The University Of Pennsylvania |
Rna zawierający zmodyfikowane nukleozydy i sposoby jego zastosowania
|
|
WO2007081680A2
(en)
|
2006-01-05 |
2007-07-19 |
The Ohio State University Research Foundation |
Microrna expression abnormalities in pancreatic endocrine and acinar tumors
|
|
EP2484782B1
(en)
|
2006-01-05 |
2015-11-18 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
|
|
EP2522748A1
(en)
|
2006-03-02 |
2012-11-14 |
The Ohio State University |
MicroRNA expression profile associated with pancreatic cancer
|
|
TW200806789A
(en)
*
|
2006-03-27 |
2008-02-01 |
Globeimmune Inc |
RAS mutation and compositions and methods related thereto
|
|
CA2664383C
(en)
|
2006-09-19 |
2017-08-22 |
Asuragen, Inc. |
Micrornas differentially expressed in pancreatic diseases and uses thereof
|
|
WO2008054828A2
(en)
|
2006-11-01 |
2008-05-08 |
The Ohio State University Research Foundation |
Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma
|
|
CN101622348A
(zh)
|
2006-12-08 |
2010-01-06 |
奥斯瑞根公司 |
作为治疗性干预靶标的miR-20调节的基因和途径
|
|
US8415096B2
(en)
|
2007-05-23 |
2013-04-09 |
University Of South Florida |
Micro-RNAs modulating immunity and inflammation
|
|
WO2008154098A2
(en)
|
2007-06-07 |
2008-12-18 |
Wisconsin Alumni Research Foundation |
Reagents and methods for mirna expression analysis and identification of cancer biomarkers
|
|
CN101784564B
(zh)
|
2007-07-13 |
2014-07-02 |
约翰霍普金斯大学 |
B7-dc变体
|
|
RS54204B1
(sr)
|
2007-07-27 |
2015-12-31 |
Immatics Biotechnologies Gmbh |
Nova imunoterapija protiv tumora mozga
|
|
PT2201100E
(pt)
|
2007-09-14 |
2016-06-03 |
Univ Brussel Vrije |
Aperfeiçoamento da capacidade estimulatória de células t das células que apresentam antígeno humano e o seu uso na vacinação
|
|
WO2009046738A1
(en)
*
|
2007-10-09 |
2009-04-16 |
Curevac Gmbh |
Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
|
|
EP2225396A4
(en)
|
2007-11-30 |
2011-03-02 |
Univ Ohio State Res Found |
PROFILING AND SCREENING OF MICRO-RNA EXPRESSION IN PERIPHERAL BLOOD IN LUNG CANCER
|
|
WO2009111088A2
(en)
|
2008-01-02 |
2009-09-11 |
The Johns Hopkins University |
Antitumor immunization by liposomal delivery of vaccine to the spleen
|
|
WO2009100430A2
(en)
|
2008-02-08 |
2009-08-13 |
Asuragen, Inc |
miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS
|
|
JP2011517932A
(ja)
|
2008-02-28 |
2011-06-23 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
ヒト慢性リンパ球性白血病(ccl)と関連するマイクロrnaシグネチャーおよびその使用
|
|
EP2112235A1
(en)
|
2008-04-24 |
2009-10-28 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Compositions and methods for microRNA expression profiling of nasopharyngeal carcinoma
|
|
WO2009149539A1
(en)
|
2008-06-10 |
2009-12-17 |
Université de Montréal |
Enhancing antigen-specific cd8+ t cell response using irf-7 mrna
|
|
EP2324044A4
(en)
|
2008-08-04 |
2012-04-25 |
Univ Miami |
STING (STIMULATOR OF INTERFERON GENES) AS A REGULATOR OF BORROWING IMMUNE REACTIONS
|
|
WO2010018563A2
(en)
|
2008-08-12 |
2010-02-18 |
Rosetta Genomics Ltd. |
Compositions and methods for the prognosis of lymphoma
|
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
|
US9074206B2
(en)
|
2008-11-13 |
2015-07-07 |
Fudan University |
Compositions and methods for micro-RNA expression profiling of colorectal cancer
|
|
US20120053224A1
(en)
|
2008-12-10 |
2012-03-01 |
Universitat Regensburg |
Compositions and methods for micro-rna expression profiling of cancer stem cells
|
|
EP2246433A1
(de)
*
|
2009-04-30 |
2010-11-03 |
Mologen AG |
Concatemere zur Immunmodulation
|
|
US20120264626A1
(en)
|
2009-05-08 |
2012-10-18 |
The Ohio State University Research Foundation |
MicroRNA Expression Profiling and Targeting in Chronic Obstructive Pulmonary Disease (COPD) Lung Tissue and Methods of Use Thereof
|
|
KR20220038506A
(ko)
|
2009-06-10 |
2022-03-28 |
알닐람 파마슈티칼스 인코포레이티드 |
향상된 지질 조성물
|
|
WO2011076142A1
(en)
|
2009-12-24 |
2011-06-30 |
Fudan University |
Compositions and methods for microrna expession profiling in plasma of colorectal cancer
|
|
WO2011076143A1
(en)
|
2009-12-24 |
2011-06-30 |
Fudan University |
Compositions and methods for microrna expression profiling of lung cancer
|
|
EP2341145A1
(en)
|
2009-12-30 |
2011-07-06 |
febit holding GmbH |
miRNA fingerprint in the diagnosis of diseases
|
|
WO2011094683A2
(en)
|
2010-01-29 |
2011-08-04 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Method of identifying myelodysplastic syndromes
|
|
EP2354246A1
(en)
|
2010-02-05 |
2011-08-10 |
febit holding GmbH |
miRNA in the diagnosis of ovarian cancer
|
|
US20130059015A1
(en)
|
2010-03-11 |
2013-03-07 |
H. Lee Moffitt Cancer Center & Research Institute |
Human Cancer micro-RNA Expression Profiles Predictive of Chemo-Response
|
|
US9115402B2
(en)
*
|
2010-05-14 |
2015-08-25 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods of identifying tumor specific neoantigens
|
|
WO2011157294A1
(en)
|
2010-06-16 |
2011-12-22 |
Universita' Degli Studi Di Padova |
Compositions for use in treating or preventing cancer, breast cancer, lung cancer, ovarian cancer, metastasis, heart failure, cardiac remodelling, dilated cardiomyopathy, autoimmune diseases, or diseases or disorders related thereto
|
|
JP5911870B2
(ja)
*
|
2010-08-31 |
2016-04-27 |
ノバルティス アーゲー |
免疫原をコードするrnaの送達のためのpeg化リポソーム
|
|
RS63890B1
(sr)
*
|
2010-08-31 |
2023-02-28 |
Glaxosmithkline Biologicals Sa |
Mali lipozomi za isporuku rnk koja kodira imunogen
|
|
EP2857499A1
(en)
|
2010-10-01 |
2015-04-08 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
US9862968B2
(en)
|
2010-10-26 |
2018-01-09 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
NF-κB signaling pathway-manipulated dendritic cells
|
|
US9999673B2
(en)
|
2011-01-11 |
2018-06-19 |
Alnylam Pharmaceuticals, Inc. |
PEGylated lipids and their use for drug delivery
|
|
WO2012151212A1
(en)
|
2011-05-01 |
2012-11-08 |
University Of Rochester |
Multifocal hepatocellular carcinoma microrna expression patterns and uses thereof
|
|
US20130042333A1
(en)
|
2011-05-06 |
2013-02-14 |
Jean-Gabriel JUDDE |
Markers for cancer prognosis and therapy and methods of use
|
|
CA2835641C
(en)
|
2011-05-11 |
2019-05-28 |
Exosome Diagnostics, Inc. |
Nucleic acid extraction from heterogeneous biological materials
|
|
CN103687957A
(zh)
*
|
2011-05-17 |
2014-03-26 |
现代治疗公司 |
工程化核酸及其用于非人类脊椎动物的方法
|
|
US8691750B2
(en)
|
2011-05-17 |
2014-04-08 |
Axolabs Gmbh |
Lipids and compositions for intracellular delivery of biologically active compounds
|
|
LT2714071T
(lt)
*
|
2011-05-24 |
2019-10-10 |
Biontech Rna Pharmaceuticals Gmbh |
Individualizuotos vakcinos nuo vėžio
|
|
EP4074693A1
(en)
|
2011-06-08 |
2022-10-19 |
Translate Bio, Inc. |
Cleavable lipids
|
|
JP5965481B2
(ja)
|
2011-07-15 |
2016-08-03 |
レオ ファーマ アクティーゼルスカブ |
皮膚t細胞リンパ腫(ctcl)の診断用マイクロrnaプロファイリング
|
|
WO2013033640A1
(en)
|
2011-09-01 |
2013-03-07 |
Allegro Diagnostics Corp. |
Methods and compositions for detecting cancer based on mirna expression profiles
|
|
EP2753345B1
(en)
|
2011-09-06 |
2016-07-13 |
Agency For Science, Technology And Research |
Polypeptide vaccine
|
|
US20140243240A1
(en)
|
2011-10-26 |
2014-08-28 |
Georgetown University |
microRNA EXPRESSION PROFILING OF THYROID CANCER
|
|
WO2013078199A2
(en)
|
2011-11-23 |
2013-05-30 |
Children's Medical Center Corporation |
Methods for enhanced in vivo delivery of synthetic, modified rnas
|
|
DE21212055T1
(de)
|
2011-12-07 |
2022-08-04 |
Alnylam Pharmaceuticals, Inc. |
Biologisch abbaubare lipide zur freisetzung von wirkstoffen
|
|
ES2923757T3
(es)
*
|
2011-12-16 |
2022-09-30 |
Modernatx Inc |
Composiciones de ARNm modificado
|
|
WO2013103659A1
(en)
|
2012-01-04 |
2013-07-11 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus
|
|
WO2013116126A1
(en)
|
2012-02-01 |
2013-08-08 |
Merck Sharp & Dohme Corp. |
Novel low molecular weight, biodegradable cationic lipids for oligonucleotide delivery
|
|
WO2013120500A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
|
|
WO2013151664A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins
|
|
CN103547683A
(zh)
*
|
2012-03-22 |
2014-01-29 |
耶鲁大学 |
Kras突变和肿瘤生物学
|
|
CN104411338A
(zh)
|
2012-04-02 |
2015-03-11 |
现代治疗公司 |
用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸
|
|
AU2013256468A1
(en)
|
2012-04-30 |
2014-12-04 |
Glen N. Barber |
Modulating immune responses
|
|
JP6283661B2
(ja)
*
|
2012-05-09 |
2018-02-21 |
ストライク バイオ インク.Strike Bio,Inc. |
一塩基KRAS変異に特異的な二機能性低分子ヘアピン型RNA(BI−SHRNA,Bi−functionalShort−HairpinRNA)
|
|
EP2858722B8
(en)
|
2012-06-08 |
2018-02-21 |
Aduro BioTech, Inc. |
Compostions and methods for cancer immunotherapy
|
|
AU2013291125A1
(en)
*
|
2012-07-16 |
2015-01-22 |
Dicerna Pharmaceuticals, Inc. |
RNAi pharmaceutical composition capable of suppressing expression of KRAS gene
|
|
EP2892549A1
(en)
|
2012-09-04 |
2015-07-15 |
Bavarian Nordic A/S |
Methods and compositions for enhancing vaccine immune responses
|
|
US10093701B2
(en)
|
2012-09-07 |
2018-10-09 |
University Of Miami |
Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
|
|
WO2014093924A1
(en)
|
2012-12-13 |
2014-06-19 |
Moderna Therapeutics, Inc. |
Modified nucleic acid molecules and uses thereof
|
|
PT2922554T
(pt)
|
2012-11-26 |
2022-06-28 |
Modernatx Inc |
Arn modificado nas porções terminais
|
|
AU2013351542B2
(en)
|
2012-11-28 |
2018-08-09 |
BioNTech SE |
Individualized vaccines for cancer
|
|
EP3434774A1
(en)
|
2013-01-17 |
2019-01-30 |
ModernaTX, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
|
WO2014127296A1
(en)
|
2013-02-14 |
2014-08-21 |
Immunocellular Therapeutics, Ltd |
Cancer vaccines and vaccination methods
|
|
WO2014164253A1
(en)
|
2013-03-09 |
2014-10-09 |
Moderna Therapeutics, Inc. |
Heterologous untranslated regions for mrna
|
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
|
CA2898130A1
(en)
|
2013-03-15 |
2014-09-18 |
The Trustees Of The University Of Pennsylvania |
Vaccines with biomolecular adjuvants
|
|
EP2983705A2
(en)
|
2013-04-10 |
2016-02-17 |
Skau Aps |
Use of immune suppressive peptides as adjuvants
|
|
JP2016524593A
(ja)
|
2013-04-29 |
2016-08-18 |
メモリアル スローン−ケタリング キャンサー センター |
セカンドメッセンジャーのシグナル伝達を変えるための組成物及び方法
|
|
CN105377867B
(zh)
|
2013-05-03 |
2019-11-12 |
加利福尼亚大学董事会 |
I型干扰素的环状二核苷酸诱导
|
|
EP2996472B1
(en)
|
2013-05-18 |
2019-03-27 |
Aduro Biotech, Inc. |
Compositions and methods for inhibiting "stimulator of interferon gene" dependent signalling
|
|
CU24377B1
(es)
|
2013-05-18 |
2018-12-05 |
Aduro Biotech Inc |
Dinucléotidos de purina cíclicos y composiciones de los mismos útiles para inducir la producción de interferón de tipo i dependientes de sting
|
|
US10176292B2
(en)
|
2013-07-31 |
2019-01-08 |
Memorial Sloan-Kettering Cancer Center |
STING crystals and modulators
|
|
AU2014340269B2
(en)
|
2013-10-21 |
2018-06-21 |
Drexel University |
Use of STING agonists to treat chronic hepatitis B virus infection
|
|
GB201319446D0
(en)
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
|
JP2016538344A
(ja)
|
2013-11-19 |
2016-12-08 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
癌処置としてのstingアゴニストの使用
|
|
BR112016013138A2
(pt)
|
2013-12-09 |
2018-01-16 |
Targovax Asa |
mistura de peptídeos
|
|
US10421971B2
(en)
|
2014-01-15 |
2019-09-24 |
The University Of Chicago |
Anti-tumor therapy
|
|
WO2015123532A1
(en)
*
|
2014-02-16 |
2015-08-20 |
Globeimmune, Inc. |
Ras g12r immunotherapy for ras mutation-positive cancers
|
|
WO2015130584A2
(en)
|
2014-02-25 |
2015-09-03 |
Merck Sharp & Dohme Corp. |
Lipid nanoparticle vaccine adjuvants and antigen delivery systems
|
|
EP3119893A1
(en)
|
2014-03-17 |
2017-01-25 |
Taplmmune Inc. |
Nucleic acid molecule vaccine compositions and uses thereof
|
|
HRP20220070T1
(hr)
*
|
2014-04-23 |
2022-04-01 |
Modernatx, Inc. |
Cjepiva nukleinske kiseline
|
|
EP3134546A4
(en)
*
|
2014-04-24 |
2017-12-06 |
Dana-Farber Cancer Institute, Inc. |
Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response
|
|
CA2947963A1
(en)
*
|
2014-05-06 |
2015-11-12 |
Targovax Asa |
Peptide vaccine comprising mutant ras peptide and chemotherapeutic agent
|
|
CA2953341C
(en)
|
2014-06-25 |
2023-01-24 |
Acuitas Therapeutics Inc. |
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
CA2960087C
(en)
|
2014-09-26 |
2024-02-27 |
Bavarian Nordic A/S |
Methods and compositions for intra-nasal immunization with recombinant mva encoding flagellin
|
|
MA40737A
(fr)
|
2014-11-21 |
2017-07-04 |
Memorial Sloan Kettering Cancer Center |
Déterminants de la réponse d'un cancer à une immunothérapie par blocage de pd-1
|
|
AU2016238290B9
(en)
|
2015-03-25 |
2019-06-13 |
The Regents Of The University Of Michigan |
Compositions and methods for delivery of biomacromolecule agents
|
|
AU2016251687C1
(en)
|
2015-04-22 |
2023-07-27 |
CureVac SE |
RNA containing composition for treatment of tumor diseases
|
|
WO2016176330A1
(en)
|
2015-04-27 |
2016-11-03 |
The Trustees Of The University Of Pennsylvania |
Nucleoside-modified rna for inducing an adaptive immune response
|
|
JP6913032B2
(ja)
|
2015-05-20 |
2021-08-04 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
共通ネオ抗原
|
|
KR20180027516A
(ko)
|
2015-06-11 |
2018-03-14 |
유니버시티 오브 마이애미 |
암 치료 및 진단
|
|
JP2018518177A
(ja)
*
|
2015-06-16 |
2018-07-12 |
タルゴバックス エーエスエー |
Rasタンパク質の突然変異フラグメント
|
|
EP3310384A1
(en)
|
2015-06-17 |
2018-04-25 |
CureVac AG |
Vaccine composition
|
|
MA42502A
(fr)
*
|
2015-07-21 |
2018-05-30 |
Modernatx Inc |
Vaccins contre une maladie infectieuse
|
|
EP3328394A4
(en)
*
|
2015-07-30 |
2019-03-13 |
ModernaTX, Inc. |
CONCATEMEE peptide epitope RNAs
|
|
AU2016303497A1
(en)
|
2015-07-31 |
2018-03-01 |
Tarveda Therapeutics, Inc. |
Compositions and methods for immuno-oncology therapies
|
|
HRP20220156T1
(hr)
*
|
2015-09-17 |
2022-04-15 |
Modernatx, Inc. |
Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
|
|
US10322177B2
(en)
|
2015-10-07 |
2019-06-18 |
Nant Holdings Ip, Llc |
Activation of immune-related signaling pathways in cells via optofection
|
|
CN108601820A
(zh)
|
2015-10-12 |
2018-09-28 |
南托米克斯有限责任公司 |
用于病毒癌症新表位的组合物和方法
|
|
EP3365006A1
(en)
|
2015-10-19 |
2018-08-29 |
Cadila Healthcare Limited |
New adjuvant and vaccine composition containing the same
|
|
EP3364949A4
(en)
*
|
2015-10-22 |
2019-07-31 |
ModernaTX, Inc. |
CANCER VACCINES
|
|
CN108368028B
(zh)
|
2015-10-28 |
2021-09-03 |
爱康泰生治疗公司 |
用于递送核酸的新型脂质和脂质纳米颗粒制剂
|
|
EP3393511A1
(en)
|
2015-12-21 |
2018-10-31 |
La Jolla Institute for Allergy and Immunology |
Leveraging immune memory from common childhood vaccines to fight disease
|
|
WO2017118702A1
(en)
|
2016-01-08 |
2017-07-13 |
Vaccibody As |
Neoepitope rna cancer vaccine
|
|
WO2017152042A2
(en)
|
2016-03-04 |
2017-09-08 |
New York University |
Virus vectors expressing multiple epitopes of tumor associated antigens for inducing antitumor immunity
|
|
WO2017177204A1
(en)
|
2016-04-09 |
2017-10-12 |
La Jolla Institute For Allergy And Immunology |
Leveraging immune memory from common childhood vaccines to fight disease
|
|
CN109328070A
(zh)
|
2016-05-04 |
2019-02-12 |
免疫疫苗技术有限公司 |
包含两亲化合物、新抗原和疏水载体的疫苗组合物及其使用方法
|
|
WO2017191274A2
(en)
|
2016-05-04 |
2017-11-09 |
Curevac Ag |
Rna encoding a therapeutic protein
|
|
EP3735984A1
(en)
|
2016-05-27 |
2020-11-11 |
Etubics Corporation |
Neoepitope vaccine compositions and methods of use thereof
|
|
EP3471778A4
(en)
|
2016-06-20 |
2020-02-19 |
The Regents of The University of Michigan |
COMPOSITIONS AND METHOD FOR DELIVERING BIOMACROMOLECOLIC ACTIVE SUBSTANCES
|
|
CA3031003A1
(en)
|
2016-07-20 |
2018-01-25 |
Biontech Rna Pharmaceuticals Gmbh |
Selecting neoepitopes as disease-specific targets for therapy with enhanced efficacy
|
|
WO2018039303A1
(en)
|
2016-08-23 |
2018-03-01 |
Schentag Jerome J |
Cholesteryl ester vesicles loading peptides, proteins and nucleic acids into chylomicrons and body cells
|
|
CA3042015A1
(en)
*
|
2016-10-26 |
2018-05-03 |
Modernatx, Inc. |
Messenger ribonucleic acids for enhancing immune responses and methods of use thereof
|
|
CN110167586B
(zh)
|
2016-11-04 |
2024-01-30 |
霍欧奇帕生物科技有限公司 |
作为癌症疫苗的复制-缺陷型沙粒病毒颗粒和三-节段沙粒病毒颗粒
|
|
KR20190082850A
(ko)
|
2016-11-30 |
2019-07-10 |
어드박시스, 인크. |
반복되는 암 돌연변이를 표적화하는 면역원 조성물 및 그것의 사용 방법
|
|
WO2018102585A1
(en)
|
2016-11-30 |
2018-06-07 |
Advaxis, Inc. |
Personalized immunotherapy in combination with immunotherapy targeting recurrent cancer mutations
|
|
WO2018111902A1
(en)
|
2016-12-12 |
2018-06-21 |
Multivir Inc. |
Methods and compositions comprising viral gene therapy and an immune checkpoint inhibitor for treatment and prevention of cancer and infectious diseases
|
|
MX2019009070A
(es)
|
2017-02-01 |
2019-10-30 |
Modernatx Inc |
Composiciones de arnm terapeuticas inmunomoduladoras que codifican peptidos de mutacion de oncogenes de activacion.
|